| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a0bdf0c590cd35f426b0b80b2a288dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_875e479ccc400b852a53fadf85434fe8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82787c2fee17b0b0eb295d5af7d2325f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eef53c79b3ba24e5812d312af9fe4df9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate |
2007-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9facfa522cb57058e9049ce6c14262fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f92a90440d2354b316a5217f10463b95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd8a804dce8c7ea261b0846892e3fa3 |
| publicationDate |
2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007145365-A1 |
| titleOfInvention |
Therapeutic agent for cancer and method for screening for the same |
| abstract |
Disclosed is a method for screening for a therapeutic agent for cancer, comprising the steps of adding a candidate substance to a test system in the presence of a cancer gene product Rda9 and a cancer suppressor gene product p53 and selecting a biologically active substance capable of controlling the binding between Rda9 and p53. Also disclosed is a therapeutic agent for cancer, which an control the binding between Rda9 and p53. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022047038-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022212180-A1 |
| priorityDate |
2006-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |